Regenxbio Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.03

+0.15 (+1.90%)

As of Sep 22, 2:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 84%

Hold 3 16%

Sell 0 0%

Price Target

Analyst Price Target +130.1% upside

Low Target $13.35

Average Target $18.48

High Target $24.09

Current Price $8.03

Current
$8.03

Target
$18.48

$13.35 $18.48 avg $24.09

Scenario Analysis

Bear Case

$13.35

66.3%

Low target

Base Case

$18.48

+130.1%

Avg target

Bull Case

$24.09

+200.0%

High target

Risk/Reward

3.0x

Highly favorable

Price in Context

52-Week High

$16.19

-50.4% from high

52-Week Low

$5.46

+47.2% from low

Target vs 52W High

$18.48

+14.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%